These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37248913)

  • 21. Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis.
    Fox D; To TM; Seetasith A; Patel AM; Iannaccone ST
    Adv Ther; 2023 Mar; 40(3):903-919. PubMed ID: 36534265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforaminal intrathecal delivery of nusinersen for older children and adults with spinal muscular atrophy and complex spinal anatomy: an analysis of 200 consecutive injections.
    Weaver JJ; Hallam DK; Chick JFB; Vaidya S; Shin DS; Natarajan N; Rad N; Reis J; Koo KSH; Shivaram GM; Thibodeau A; Apkon S; Monroe EJ
    J Neurointerv Surg; 2021 Jan; 13(1):75-78. PubMed ID: 32471828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment.
    Scheijmans FEV; Cuppen I; Zwartkruis MM; Signoria I; van Ekris C; Asselman F; Wadman RI; Knol EF; van der Pol WL; Groen EJN
    Eur J Paediatr Neurol; 2023 Jan; 42():34-41. PubMed ID: 36525882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal delivery of nusinersen in individuals with complicated spines.
    Cartwright MS; Ward ZT; White EP; West TG
    Muscle Nerve; 2020 Jul; 62(1):114-118. PubMed ID: 32319101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience.
    Veerapandiyan A; Eichinger K; Guntrum D; Kwon J; Baker L; Collins E; Ciafaloni E
    Muscle Nerve; 2020 Feb; 61(2):222-226. PubMed ID: 31773738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of nusinersen via paramedian approach for spinal muscular atrophy.
    Iwayama H; Wakao N; Kurahashi H; Kubota N; Hattori A; Kumagai T; Okumura A
    Brain Dev; 2021 Jan; 43(1):121-126. PubMed ID: 32773161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
    Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
    Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1.
    Pechmann A; Langer T; Wider S; Kirschner J
    Eur J Paediatr Neurol; 2018 Jan; 22(1):122-127. PubMed ID: 29208343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach.
    Bortolani S; Stura G; Ventilii G; Vercelli L; Rolle E; Ricci F; Bergui M; Mongini T
    Neuromuscul Disord; 2019 Oct; 29(10):742-746. PubMed ID: 31604650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A spontaneous bilateral subdural effusion in an 11-year-old boy with middle cranial fossa arachnoid cyst].
    Kumada T; Mutoh K; Sakaguchi M; Murata K
    No To Hattatsu; 2003 Jul; 35(4):342-6. PubMed ID: 12875213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound assisted lumbar intrathecal administration of nusinersen in adult patients with spinal muscular atrophy: A case series.
    Zanfini BA; Catarci S; Patanella AK; Pane M; Frassanito L; Filipponi E; Mercuri E; Sabatelli M; Draisci G
    Muscle Nerve; 2021 Nov; 64(5):594-599. PubMed ID: 34396547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A horizontal and perpendicular interlaminar approach for intrathecal nusinersen injection in patients with spinal muscular atrophy and scoliosis: an observational study.
    Huang C; Zhang Y; Diedrich DA; Li J; Luo W; Zhao X; Guo Y; Luo Y; Zhang T; Wang X; Huang W; Xiao Y
    Orphanet J Rare Dis; 2024 Jul; 19(1):268. PubMed ID: 39010073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory monitoring of nusinersen safety.
    Goedeker NL; Gibbons JL; Varadhachary AS; Connolly AM; Zaidman CM
    Muscle Nerve; 2021 Jun; 63(6):902-905. PubMed ID: 33675054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic Model.
    MacCannell D; Berger Z; Kirschner J; Mercuri E; Farrar MA; Iannaccone ST; Kuntz NL; Finkel RS; Valente M; Muntoni F
    CNS Drugs; 2022 Feb; 36(2):181-190. PubMed ID: 35080757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound-guided nusinersen administration for spinal muscular atrophy patients with severe scoliosis: an observational study.
    Zhang J; Cui X; Chen S; Dai Y; Huang Y; Zhang S
    Orphanet J Rare Dis; 2021 Jun; 16(1):274. PubMed ID: 34120632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Needleless inhaled anesthesia with sevoflurane: Advantages of a simplified approach for children with spinal muscular atrophy undergoing intrathecal administration of nusinersen.
    Salerno A; Picconi E; Genovese O; Piastra M; Pulitanò SM; Tosi F; Mancino A; Pane M; De Sanctis R; Carlini D; Mercuri EM; Conti G
    Paediatr Anaesth; 2023 Apr; 33(4):282-290. PubMed ID: 36636888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nusinersen in adult patients with spinal muscular atrophy: Observations from a single center.
    Moshe-Lilie O; Visser A; Chahin N; Ragole T; Dimitrova D; Karam C
    Neurology; 2020 Jul; 95(4):e413-e416. PubMed ID: 32665408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased intracranial pressure caused by non-space-occupying arachnoid cysts: report of two patients.
    Lindner U; Bubl B; Steudel WI; Papanagiotou P; Käsmann-Kellner B; Gortner L; Shamdeen MG
    Neuropediatrics; 2009 Apr; 40(2):89-91. PubMed ID: 19809939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nusinersen by subcutaneous intrathecal catheter for symptomatic spinal muscular atrophy patients with complex spine anatomy.
    Carson VJ; Young M; Brigatti KW; Robinson DL; Reed RM; Sohn J; Petrillo M; Farwell W; Miller F; Strauss KA
    Muscle Nerve; 2022 Jan; 65(1):51-59. PubMed ID: 34606118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nusinersen for the treatment of spinal muscular atrophy.
    Chiriboga CA
    Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.